(Q40779153)

English

Combined interferon and vinblastine treatment of advanced melanoma: evaluation of the treatment results and the effects of the treatment on immunological functions

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

23 September 2017

Combined interferon and vinblastine treatment of advanced melanoma: evaluation of the treatment results and the effects of the treatment on immunological functions (English)

1 reference

Europe PubMed Central

23 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

P Kellokumpu-Lehtinen

1

1 reference

Europe PubMed Central

23 September 2017

E Nordman

2

1 reference

Europe PubMed Central

23 September 2017

A Toivanen

3

1 reference

Europe PubMed Central

23 September 2017

publication date

1 January 1989

1 reference

Europe PubMed Central

23 September 2017

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

23 September 2017

28

1 reference

Europe PubMed Central

23 September 2017

213-217

1 reference

Europe PubMed Central

23 September 2017

3

1 reference

Europe PubMed Central

23 September 2017

https://scigraph.springernature.com/pub.10.1007/bf00204991

0 references

Binding of human alpha-interferons to natural killer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2784356

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical significance of natural killer cell cytotoxicity: need for proper data analysis in the design of clinical studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/2784356

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II results with recombinant interferons: renal cell carcinoma and malignant melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2784356

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A New Micromethod for Lymphocyte Stimulation Using Whole Blood

1 reference

https://pubmed.ncbi.nlm.nih.gov/2784356

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Melanoma: therapeutic options with recombinant interferons

1 reference

https://pubmed.ncbi.nlm.nih.gov/2784356

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of long-term administration of recombinant alpha-2 interferon on lymphocyte subsets, proliferation, and suppressor cell function in multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2784356

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and tolerance of recombinant interferon alfa-2a (Roferon-A) in cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/2784356

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural killer cells and their relationship to T-cells: hypothesis on the role of T-cell receptor gene rearrangement on the course of adaptive differentiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/2784356

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized trial of levamisole versus placebo as adjuvant therapy in malignant melanoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2784356

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Controlled study with imidazole carboxamide (DTIC), DTIC + bacillus Calmette-Guérin (BCG), and DTIC + corynebacterium parvum in advanced malignant melanoma. W.H.O. Collaborating Centres for Evaluation of Methods of Diagnosis and Treatment of Melanom

1 reference

https://pubmed.ncbi.nlm.nih.gov/2784356

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized trial of adjuvant chemotherapy and immunotherapy in cutaneous melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2784356

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunological effects of recombinant interferon alfa-2a in patients with disseminated melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2784356

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural cytotoxic reactivity of human lymphocytes against a myeloid cell line: characterization of effector cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2784356

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/2784356

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphocyte subpopulations in patients with breast cancer after postoperative radiotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/2784356

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reporting results of cancer treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/2784356

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant interferon alfa-2a in advanced malignant melanoma. A phase I-II study in combination with DTIC.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2784356

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Three consecutive phase II studies of recombinant interferon alfa-2a in advanced malignant melanoma. Updated analyses

1 reference

https://pubmed.ncbi.nlm.nih.gov/2784356

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00204991

1 reference

Europe PubMed Central

23 September 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

23 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40779153&oldid=1907295278"